Respiratory morbidity 20 years after RSV infection in infancy

M Korppi1, E Piippo-Savolainen, K Korhonen

  • 1Department of Pediatrics, Kuopio University and University Hospital, Finland. matti.korppi@uku.fi

Pediatric Pulmonology
|June 24, 2004
PubMed

Insights

Infants hospitalized with respiratory syncytial virus (RSV) infection show increased risk for abnormal lung function in adulthood. Early RSV infection is an independent risk factor for reduced lung function, but not asthma or bronchial reactivity.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Epidemiology

Background:

  • Early-life respiratory syncytial virus (RSV) infection is a suspected risk factor for adult asthma.
  • Prospective studies tracking RSV infection from infancy through adulthood are lacking.

Purpose of the Study:

  • To evaluate early-life RSV infection as a risk factor for adult asthma, bronchial reactivity, and lung function abnormalities.
  • To investigate the long-term respiratory health outcomes in young adults previously hospitalized for RSV bronchiolitis or pneumonia.

Main Methods:

  • A prospective cohort study followed children hospitalized for RSV before age 24 months until ages 18-20 years.
  • Methods included questionnaires, spirometry (FVS), methacholine challenge (MIC), home peak expiratory flow (PEF) monitoring, and skin prick tests (SPT).

Main Results:

  • 17-22% of RSV-exposed subjects had asthma; 44% had abnormal lung function compared to 11% of controls.
  • RSV infection in infancy was an independent risk factor for lung function abnormality (OR, 5.27) and decreased FEV% and MEF50.
  • No significant association was found between early RSV infection and asthma or bronchial reactivity.

Conclusions:

  • Hospitalization for RSV in infancy is an independent risk factor for developing lung function abnormalities in young adulthood.
  • While not directly linked to asthma or bronchial hyperresponsiveness, early RSV infection has lasting impacts on lung function.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...